Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627800 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL796577 | 0.95 | — | — | |
| Iodide SCHEMBL2551034 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL7929891 | 0.93 | — | — | |
| SCHEMBL2476646 | 0.89 | — | — | |
| Thiocyanic Acid SCHEMBL6033374 | 0.86 | — | — | |
| Acetic Acid SCHEMBL528342 | 0.84 | — | — | |
| SCHEMBL5071335 | 0.82 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL5700772 | 0.80 | KCNH2 (0.36) | — | |
| Trifluoroacetic Acid SCHEMBL17965966 | 0.80 | CCR5 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4456216-A1 | POLYELECTROLYTE MEMBRANE HAVING, AS BASE THEREFOR, POLYMER HAVING HIGH DENSITY OF ACIDIC FUNCTIONAL GROUPS | National University Corporation Tokai National Higher Education and Research System (JP) | 2024-10-30 | — | — | EP | disclosed |
| US-11612602-B2 | Heterocyclic compounds and uses as anticancer agents | ACEA Therapeutics, Inc. (US) | 2023-03-28 | — | — | US | disclosed |
| US-20210100802-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | ACEA Therapeutics, Inc. (US) | 2021-04-08 | — | — | US | disclosed |
| EP-2802568-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS. | Acea Biosciences, Inc. (US) | 2014-11-19 | — | — | EP | disclosed |
| US-20130253214-A1 | CLAY DISPERSION, METHOD FOR MANUFACTURING THE SAME AND CLAY THIN FILM | TOMOEGAWA CO LTD (JP) | 2013-09-26 | — | — | US | disclosed |
| WO-2013106792-A1 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS. | ACEA BIOSCIENCES INC. (US) | 2013-07-18 | — | — | WO | disclosed |
| US-20120145038-A1 | CLAY DISPERSION LIQUID, AND METHOD FOR PRODUCING THE SAME, CLAY FILM, AND METHOD FOR PRODUCING THE SAME, AND TRANSPARENT MATERIAL | TOMOEGAWA CO., LTD. (JP) | 2012-06-14 | — | — | US | disclosed |
| EP-2060538-B1 | Clay dispersion, method for manufacturing the same and clay thin film | TOMOEGAWA CO LTD (JP) | 2011-08-31 | — | — | EP | disclosed |
| WO-2009135600-A1 | CATALYSTS FOR THE SYNTHESIS OF POLYURETHANES | BAYER MATERIALSCIENCE AG (DE) | 2009-11-12 | — | — | WO | disclosed |
| EP-2060538-A2 | Clay dispersion, method for manufacturing the same and clay thin film | Tomoegawa Co., Ltd. (JP) | 2009-05-20 | — | — | EP | disclosed |
| US-20090120326-A1 | CLAY DISPERSION, METHOD FOR MANUFACTURING THE SAME AND CLAY THIN FILM | TOMOEGAWA CO., LTD. (JP) | 2009-05-14 | — | — | US | disclosed |